Page last updated: 2024-09-04

atrasentan and Dyspnea

atrasentan has been researched along with Dyspnea in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kantoff, P; Kaufman, DS; Michaelson, MD; Oh, WK; Smith, MR1

Trials

1 trial(s) available for atrasentan and Dyspnea

ArticleYear
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.
    Cancer, 2006, Aug-01, Volume: 107, Issue:3

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Disease Progression; Dyspnea; Edema; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Treatment Outcome; Zoledronic Acid

2006